/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation
Event: EHRA 2024
Topic: Rhythm Control, Catheter Ablation
Session: Atrial fibrillation: treatment 5 - ablation
Impact of obesity and pattern of atrial fibrillation on long-term outcome following cryoballoon pulmonary vein isolation
Event: EHRA 2024
Topic: Rhythm Control, Catheter Ablation
Session: Atrial fibrillation: treatment 4 - ablation
High-density, high-resolution mapping in patients with recurrent atrial fibrillation after cryoballoon pulmonary vein isolation: findings and outcome after repeat ablation
Event: ESC Congress 2023
Topic: Rhythm Control, Catheter Ablation
Session: Catheter ablation and hybrid ablation for atrial fibrillation
Does energy matter when performing posterior wall isolation in addition to pulmonary vein isolation at atrial fibrillation ablation: a meta-analysis
Event: ESC Congress 2023
Topic: Rhythm Control, Catheter Ablation
Session: Novel approaches and technologies for catheter ablation of atrial fibrillation
The impact of posterior wall ablation in conjunction with pulmonary vein isolation in patients with persistent atrial fibrillation: a meta-analysis comparing cryoballoon vs. radiofrequency energy
Event: EHRA 2023
Topic: Rhythm Control, Catheter Ablation
Session: ePoster session 22
The impact of atrial fibrillation burden early post cryoballoon pulmonary vein isolation on long-term freedom from recurrent atrial fibrillation
Event: EHRA 2022
Topic: Rhythm Control, Catheter Ablation
Session: ePosters Day 3
Yearly incidence and pattern of very late recurrence of atrial fibrillation as detected by continuous electrocardiographic monitoring using an implantable loop recorder
Event: EHRA 2022
Topic: Rhythm Control, Catheter Ablation
Session: ePosters Day 2
Is there clinical utility to replacement of an implantable loop recorder in patients who have previously undergone cryoballoon pulmonary vein isolation?
Event: EHRA 2022
Topic: Diagnostic Methods
Session: ePosters Day 2
Is the optimal blanking period duration after cryoballoon pulmonary vein isolation impacted by use of antiarrhythmic drugs?
Event: EHRA 2021
Topic: Rhythm Control, Catheter Ablation
Session: Treatment of atrial fibrillation and stroke prevention
Defining the blanking period duration after cryoballoon pulmonary vein isolation in patients taking an antiarrhythmic drug
Event: EHRA 2021
Topic: Rhythm Control, Catheter Ablation
Session: ePoster session
ESC 365 is supported by
